首页> 外文期刊>British Journal of Pharmacology >Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts
【24h】

Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts

机译:尿皮质激素对大鼠离体心脏缺血再灌注过程中冠状动脉内皮功能的保护作用机制

获取原文
获取原文并翻译 | 示例
       

摘要

1. Urocortin is a vasodilator peptide related to corticotrophin-releasing factor, which may protect endothelial function during coronary ischemia-reperfusion (I-R). The aim of this study was to study the mechanisms of this protective effect. 2. Hearts from Sprague-Dawley rats were isolated and perfused at constant flow and then exposed to 15 min global zero-flow ischemia, followed by 15 min reperfusion. The relaxation to acetylcholine (10 nM-10 μM) was recorded after pre-constriction of the coronary vasculature with U46619 (100-300 nM) in ischemic-reperfused or time-control hearts. 3. After I-R, the coronary relaxation to acetylcholine was reduced and this reduction was attenuated by treatment with urocortin (10 pM), administered before ischemia and during reperfusion. 4. This urocortin-induced improvement of the relaxation to acetylcholine was not modified by tetraethylammonium (10 mM), blocker of Ca~(2+) dependent-potassium channels; glibenclamide (10 μM), blocker of K_(ATP) channels; N~w-nitro-L-arginine methyl ester (L-NAME, 100 μM), blocker of nitric oxide synthesis; or meclofenamate (10 μM), blocker of cyclooxygenase, but it was abolished by chelerythrine (3 μM), blocker of protein kinase C (PKC). 5. These results suggest that urocortin may protect coronary endothelial function during I-R by activation of PKC.
机译:1. Urocortin是与促肾上腺皮质激素释放因子有关的血管扩张肽,可在冠状动脉缺血再灌注(I-R)期间保护内皮功能。这项研究的目的是研究这种保护作用的机制。 2.从Sprague-Dawley大鼠的心脏分离并以恒定流量灌注,然后暴露于15分钟的整体零流量局部缺血,随后进行15分钟的再灌注。在缺血再灌注或时间控制的心脏中,用U46619(100-300 nM)预先收缩冠状血管后,记录到乙酰胆碱(10 nM-10μM)的松弛。 3. I-R后,冠状动脉对乙酰胆碱的松弛减少,并且通过在缺血前和再灌注期间给予尿皮质激素(10 pM)治疗减弱了这种减少。 4.尿皮质素诱导的对乙酰胆碱松弛的改善没有被Ca〜(2+)依赖性钾通道的阻滞剂四乙铵(10 mM)所修饰。格列本脲(10μM),K_(ATP)通道的阻滞剂; N〜w-硝基-L-精氨酸甲酯(L-NAME,100μM),一氧化氮合成的阻滞剂;或环加氧酶阻断剂甲氯芬那酸酯(10μM),但被蛋白激酶C(PKC)阻断剂白屈菜红碱(3μM)废除。 5.这些结果表明,尿皮质素可能通过激活PKC保护I-R期间的冠状动脉内皮功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号